Raymond James Financial Services Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,505
| Closed | -$398K | – | 3394 |
|
|
2023
Q1 | $398K | Sell |
16,505
-462
| -3% | -$11.1K | ﹤0.01% | 2474 |
|
|
2022
Q4 | $179K | Buy |
+16,967
| New | +$179K | ﹤0.01% | 2889 |
|
|
2021
Q1 | – | Sell |
-33,139
| Closed | -$561K | – | 3220 |
|
|
2020
Q4 | $561K | Buy |
33,139
+5,990
| +22% | +$101K | ﹤0.01% | 2066 |
|
|
2020
Q3 | $348K | Sell |
27,149
-1,692
| -6% | -$21.7K | ﹤0.01% | 2199 |
|
|
2020
Q2 | $407K | Sell |
28,841
-12,336
| -30% | -$174K | ﹤0.01% | 2040 |
|
|
2020
Q1 | $379K | Sell |
41,177
-1,797
| -4% | -$16.5K | ﹤0.01% | 1700 |
|
|
2019
Q4 | $640K | Buy |
42,974
+11,609
| +37% | +$173K | ﹤0.01% | 1816 |
|
|
2019
Q3 | $214K | Buy |
31,365
+1,778
| +6% | +$12.1K | ﹤0.01% | 2451 |
|
|
2019
Q2 | $358K | Buy |
+29,587
| New | +$358K | ﹤0.01% | 2152 |
|